Chinese bio-pharmaceutical developer, manufacturer and marketer of oncology drugs Tot Biopharm recently a...
Alibaba Group Holding Ltd. is selling its medical assets for HK$10.6 billion ($1.4 billion) to a Hong Kong-listed unit t...
Alpha Biopharma Inc has announced the first $37 million closing of its $65 million Series A financing led by Q...
Pacira Pharmaceuticals, Inc. and Nuance Biotech Co. Ltd have entered into an agreement with Nuance, a China based specia...
The research team of Hong Kong Baptist University (HKBU) has invented a medical device with a specific nanotechnology la...
WuXi Biologics , a leading global open-access biologics technology platform company offering end-to-end solutions fo...
Bristol Myers Squibb recently announced that the China National Drug Administration (CNDA) has approved ...
AIDS remains an incurable disease. In the world, HIV/AIDS has resulted in estimated 40 million deaths while 36.9 million...
Aptose Biosciences Inc., a clinical-stage biotechnology company committed to developing personalized therapies addressin...
Parkinson’s disease is one of the leading neural degenerative disorders which is primarily caused by death of dopa...
Yaoshibang, a Guangzhou-based online pharmacy trading and education platform, recently completed a RMB420 million ($65.7...
Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., launched the Shanghai Lung ...
Suven Life Sciences said it has obtained one product patent each from China and the US related to its 5-HT4 and 5 ...
Ascletis (partner of WuXi STA) receives approval from National Drug Administration of China (CNDA, former CFDA) of its C...
Hebron Technology Co., Ltd., a developer, manufacturer and installer of valves and pipe fittings for use in the pharmace...
Shanghai Kinetic Medical Co recently announced that it plans to take over US medical technology company Elliquence LLC f...
Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specialized in the application of d...
Zai Lab, a Shanghai-based innovative biopharmaceutical company, recently announced that Mr William Liang has b...
